metaEvidence

graph Evidence gap map comparisons

	atezolizumab based treatment		avelumab based treatment	durvalumab based treatment	nivolumab based treatment	pembrolizumab based treatment		Immune checkpoint association
	atezolizumab alone	atezolizumab plus SoC	avelumab alone	durvalumab alone	nivolumab alone	pembrolizumab alone	pembrolizumab plus SoC	durvalumab plus tremelimumab

Comparator: vs no additional treatment; vs placebo; vs gemcitabine plus platin; vs placebo plus SoC; vs Standard of Care (SoC); vs BSC;
Risk of bias: low; some concerns; high; NA;